Expression of Fas-ligand in first trimester and term human placental villi

Journal of Reproductive Immunology

Volumn 46, Issue 2, 2000, Pages 83-90

  Hammer, Astrid ^a   Dohr, Gottfried ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Apoptosis; Fas ligand; Human; Immunohistochemistry; Placenta; Pregnancy; Trophoblast cells

Indexed keywords

FAS LIGAND;

ANTIGEN EXPRESSION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA VILLUS; PREGNANCY; PRIORITY JOURNAL; SHORT SURVEY; TROPHOBLAST;

EID: 0034000695     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(99)00059-5     Document Type: Article

References (19)

1. Bamberger A.M., Schulte H.M., Thuneke I., Erdmann I., Bamberger C.M., Asa S. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J. Clin. Endocrinol. Metab. 82:1997;3173-3175.
2. Beer A.E., Billingham R.E. The Immunbiology of Mammalian Reproduction. 1976;Prentice-Hall, Englewood Cliffs, NJ.
3. Bellgrau D., Gold C., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
4. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
5. Ferguson T.A., Griffith T.S. A vision of cell death: Insights into immune privilege. Immunol. Rev. 156:1997;167-184.
6. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis is a mechanism of immune privilege. Science. 270:1995;1189-1192.
7. Hammer A., Dohr G. Apoptotic nuclei within the uterine decidua of first trimester pregnancy arise from CD45 positive leukocytes. Am. J. Reprod. Immunol. 42:1999;88-94.
8. Hammer A., Blaschitz A., Daxböck C., Walcher W., Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am. J. Reprod. Immunol. 41:1999;41-51.
9. Hunt J.S., Vassner D., Ferguson T.A., Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158:1997;4122-4128.
10. Huppertz B., Frank H.G., Kingdom J.C.P., Reister F., Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem. Cell. Biol. 110:1998;495-508.
11. Kiener P.A., Davis P.M., Rankin B.M., Klebanoff S.J., Ledbetter J.A., Starling G.C., Liles W.C. Human monocyte cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159:1997;1594-1598.
12. Mor G., Gutierrez L.S., Eliza M., Kahyaoglu F., Arici A. Fas-Fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am. J. Reprod. Immunol. 40:1998;89-94.
13. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B.C., Ponstingl H., Krammer P.H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:1992;10709-10715.
14. Runic R., Lockwood C.J., Ma Y., Dipasquale B., Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol. Metab. 81:1996;3119-3122.
15. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:1994;873-879.
16. Trauth B.C., Klas C., Peters A.M.J., Matzuku S., Möller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301-305.
17. Uckan, D., Steele, A., Cherry, Wang, B.Y., Chamizo, W., Koutsonikolis, A., Gilbert-Barness, E., Good, R.A., 1997. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3, 655-662.
18. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
19. Zorzi W., Thellin O., Coumans B., Melot F., Hennen G., Lakaye B., Igout A., Heinen E. Demonstration of the expression of CD95 ligand transcript and protein in human placenta. Placenta. 19:1998;269-277.